XML 18 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid- In Capital
Accumulated Other Comprehensive (Loss) Income
Retained Deficit
Beginning balance at Sep. 30, 2024 $ 82,358 $ 143 $ 128,466 $ (720) $ (45,531)
Beginning balance (in shares) at Sep. 30, 2024   14,259,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 312       312
Translation adjustment (711)     (711)  
Stock compensation expense 333   333    
Stock options exercised 150   150    
Stock options exercised (in shares)   30,000      
Ending balance at Dec. 31, 2024 82,442 $ 143 128,949 (1,431) (45,219)
Ending balance (in shares) at Dec. 31, 2024   14,289,000      
Beginning balance at Sep. 30, 2024 82,358 $ 143 128,466 (720) (45,531)
Beginning balance (in shares) at Sep. 30, 2024   14,259,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (31,394)        
Ending balance at Jun. 30, 2025 51,718 $ 143 129,577 (1,077) (76,925)
Ending balance (in shares) at Jun. 30, 2025   14,314,000      
Beginning balance at Dec. 31, 2024 82,442 $ 143 128,949 (1,431) (45,219)
Beginning balance (in shares) at Dec. 31, 2024   14,289,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (31,812)       (31,812)
Translation adjustment 115     115  
Stock compensation expense 290   290    
RSU vested (in shares)   25,000      
Ending balance at Mar. 31, 2025 51,035 $ 143 129,239 (1,316) (77,031)
Ending balance (in shares) at Mar. 31, 2025   14,314,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 106       106
Translation adjustment 239     239  
Stock compensation expense 338   338 [1]    
Ending balance at Jun. 30, 2025 51,718 $ 143 129,577 (1,077) (76,925)
Ending balance (in shares) at Jun. 30, 2025   14,314,000      
Beginning balance at Sep. 30, 2025 $ 53,385 $ 144 130,057 (959) (75,857)
Beginning balance (in shares) at Sep. 30, 2025 14,354,797 14,355,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) $ 108       108
Translation adjustment 240     240  
Stock compensation expense [1] 199   199    
Issuance of common stock under employee stock plans, net of shares withheld for payroll taxes (28)   (28)    
Issuance of common stock under employee stock plans, net of shares withheld for payroll taxes (in shares)   6,000      
Stock options exercised 192   192    
Stock options exercised (in shares)   29,000      
Ending balance at Dec. 31, 2025 54,096 $ 144 130,420 (719) (75,749)
Ending balance (in shares) at Dec. 31, 2025   14,390,000      
Beginning balance at Sep. 30, 2025 $ 53,385 $ 144 130,057 (959) (75,857)
Beginning balance (in shares) at Sep. 30, 2025 14,354,797 14,355,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) $ 2,932        
Ending balance at Jun. 30, 2026 $ 115,601 $ 175 188,341 10 (72,925)
Ending balance (in shares) at Jun. 30, 2026 17,508,101 17,508,000      
Beginning balance at Dec. 31, 2025 $ 54,096 $ 144 130,420 (719) (75,749)
Beginning balance (in shares) at Dec. 31, 2025   14,390,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 1,166       1,166
Translation adjustment 300     300  
Stock compensation expense [1] 263   263    
Issuance of common stock under employee stock plans, net of shares withheld for payroll taxes (146) $ 1 (147)    
Issuance of common stock under employee stock plans, net of shares withheld for payroll taxes (in shares)   57,000      
Stock options exercised 320   320    
Stock options exercised (in shares)   50,000      
Ending balance at Mar. 31, 2026 55,999 $ 145 130,856 (419) (74,583)
Ending balance (in shares) at Mar. 31, 2026   14,497,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 1,658       1,658
Translation adjustment 429     429  
Stock compensation expense [1] 308   308    
Stock options exercised 676 $ 1 675    
Stock options exercised (in shares)   84,000      
Issuance of common stock in public offering, net of issuance costs (in shares)   2,927,000      
Issuance of common stock in public offering, net of issuance costs 56,531 $ 29 56,502    
Ending balance at Jun. 30, 2026 $ 115,601 $ 175 $ 188,341 $ 10 $ (72,925)
Ending balance (in shares) at Jun. 30, 2026 17,508,101 17,508,000      
[1] Excludes stock-based compensation expense classified as a liability of $50,000 in the first quarter of fiscal 2026, $65,000 in the second quarter of fiscal 2026, and $86,000 in the third quarter of fiscal 2026.